Date Initiated by Firm |
April 28, 2003 |
Date Posted |
July 30, 2003 |
Recall Status1 |
Terminated 3 on April 20, 2004 |
Recall Number |
Z-1071-03 |
Recall Event ID |
26359 |
Product |
Coulter Clone B6-FITC Reagent |
Code Information |
Lots 735512F, 735513F and 735514FR |
Recalling Firm/ Manufacturer |
Beckman Coulter Inc 200 South Kraemer Blvd W 337 Brea CA 92822
|
For Additional Information Contact |
Kathleen M. Jaker 714-961-3666
|
Manufacturer Reason for Recall |
Diminished expression on B-Cell populations when drawn in EDTA tubes, which may lead to inaccurate interpretation of phenotype results.
It was determined that choice of anticoagulant may have an effect on results for this reagent. The CD23 clone has shown a diminished expression on B-Cell populations when drawn on EDTA tubes, which may lead to inaccurate interpretation of phenotype results.
|
FDA Determined Cause 2 |
Other |
Action |
Customer letters will be sent to all known purchasers on or about 4/28/2003, also existing inventory will be reworked to include a letter describing performance issues when collection occurs using EDTA. |
Quantity in Commerce |
122 |
Distribution |
Nationwide and to Canada |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|